Life Sciences, Healthcare & Pharmaceuticals
Health & Life Sciences Regulation
The Health & Life Sciences Regulation group provides comprehensive advice to an extensive group of clients, including some of the best known multinational pharmaceutical and medical device companies having a presence in Israel, as well as to Israeli distributors of pharmaceuticals, food and food supplements, international clinical trial organisers, and a number of Israel's hospitals and health funds (HMOs) with respect to a variety of issues.
The Food and Drug Regulation group has substantial experience in all regulatory matters and requirements including with respect to: importation, registration, marketing, storage, recall procedures, clinical trials, labelling, advertising of pharmaceuticals, promotional campaigns, research and development, compliance, donations, relationship with physicians (funding, gifts, etc.), funding/sponsoring medical conventions and clinical trials and other related matters. This involves an in-depth knowledge of all aspects of the relationship between the local representatives and international pharmaceutical companies or manufacturers of medical devices and the substantive legal issues arising between such companies and healthcare providers. The team also provides advice in the area of food and food supplements, including with respect to consumer protection issues relating to the marketing and sales of such products to consumers.
Herzog Fox & Neeman regularly represents clients in the food and drug field before regulatory authorities (at the highest level) resulting in the establishment over the years of a good working relationship with the Ministry of Health and other governmental authorities.
Health & Life Sciences Regulation News & Insights
Happy Holidays! Wishing you and your loved ones health and happiness in the new year. May 2023 be an extraordinary
Happy Holidays !
We want to thank you all for tackling the challenges of 2020 with us and hope that in 2021 we
Have a Happy and Healthy New Year 2021
As you know, Israel continues its efforts to deal with the Corona Virus and contain it, to avoid its spreading
Handling the Corona Virus- Live Updates
On the 18th of June, 2018, the Ministry of Health published a circular pertaining to the rules for the commercial
Client Update | Rules for Commercial Engagements of Health Institutions
During the first half of 2018, four amendments to the legislation on cost-control of drug pricing [of preparations] in Israel
Client Update | Changes in Cost-Control Drug Pricing Policy | June 2018
The 24th Amendment of the Pharmacists Ordinance [New Version], 1981, effective as of October 2016, introduced a major reform in the enforcement